Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments (2022 - 2025)
Whitehawk Therapeutics (WHWK) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with $39.8 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 198.57% to $39.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.8 million through Dec 2025, down 5.51% year-over-year, with the annual reading at $59.8 million for FY2025, 5.51% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $39.8 million at Whitehawk Therapeutics, up from $2.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $51.2 million in Q2 2023, with the low at $2.0 million in Q3 2025.
- Average Change in Acquisitions & Divestments over 4 years is $22.1 million, with a median of $15.9 million recorded in 2024.
- Peak annual rise in Change in Acquisitions & Divestments hit 198.57% in 2025, while the deepest fall reached 86.86% in 2025.
- Over 4 years, Change in Acquisitions & Divestments stood at $12.8 million in 2022, then soared by 44.02% to $18.4 million in 2023, then fell by 27.47% to $13.3 million in 2024, then skyrocketed by 198.57% to $39.8 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $39.8 million, $2.0 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.